UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 13, 2007

	New Brunswick Scientific Co., Inc.
	(Exact name of registrant as specified in its charter)

	New Jersey		0-6994		22-1630072
	(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

	P.O. Box 4005 44 Talmadge Road Edison, New Jersey		08818-4005
	(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (732) 287-1200

	N/A
	(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition.

On August 13, 2007, New Brunswick Scientific Co., Inc. issued a press release entitled “New Brunswick Scientific Reports Second Quarter and First Half 2007 Financial Results,” a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Description of the Exhibit
99.1		Press release dated August 13, 2007, entitled “New Brunswick Scientific Reports Second Quarter and First Half 2007 Financial Results”

Signatures

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		New Brunswick Scientific Co., Inc.


Date: August 13, 2007	By:	/s/ Thomas Bocchino
		Thomas Bocchino
		Vice President, Finance and
		Chief Financial Officer

Filing Compare · NEW BRUNSWICK SCIENTIFIC CO INC